tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

10X Genomics Inc

TXG
Add to Watchlist
48.400USD
+0.340+0.71%
Close 07-23 16:00（ET）Quotes delayed by 15 min
6.18BMarket Cap
LossP/E TTM

10X Genomics Inc

48.400
+0.340+0.71%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

TXG Financials

See 10X Genomics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

10X Genomics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.24
Revenue / Forecast
--/146.66M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
642.82M
5.25%
EPS(YoY)
-0.35
76.98%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
62.53%-0.10
68.29%-0.13
26.08%-0.22
188.42%0.28
44.19%-0.28
2.33%-0.40
62.51%-0.30
40.98%-0.32
-14.40%-0.50
-175.21%-0.41
---0.79
---0.53
---0.44
---0.15
---1.31
----
----
----
----
----
Revenue
-2.61%150.84M
0.61%166.03M
-1.75%149.00M
12.93%172.91M
9.84%154.88M
-10.30%165.02M
-1.30%151.65M
4.28%153.10M
5.01%141.01M
17.76%183.98M
17.22%153.64M
28.10%146.82M
17.28%134.28M
8.85%156.23M
4.61%131.07M
-1.06%114.61M
8.20%114.50M
27.90%143.53M
74.47%125.30M
170.00%115.84M
Net Profit
60.80%-13.47M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.90M
-18.13%-59.95M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
6.69%-17.21M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
95.56%-18.45M
73.92%-17.17M
72.48%-11.05M
Net Margin
59.75%-8.93%
67.05%-9.79%
21.79%-18.44%
180.70%19.97%
47.82%-22.18%
-11.66%-29.71%
61.05%-23.58%
41.77%-24.75%
-12.50%-42.52%
-141.47%-26.61%
---60.52%
---42.51%
---37.79%
---11.02%
---41.31%
----
----
----
----
----
Gross Margin
3.39%70.39%
1.35%68.15%
-4.04%67.32%
6.27%72.34%
2.99%68.08%
6.84%67.24%
12.83%70.16%
0.33%68.07%
-9.78%66.11%
-17.66%62.93%
--62.18%
--67.85%
--73.27%
--76.43%
--76.80%
----
----
----
----
----
Income Statement
Revenue
-2.61%150.84M
0.61%166.03M
-1.75%149.00M
12.93%172.91M
9.84%154.88M
-10.30%165.02M
-1.30%151.65M
4.28%153.10M
5.01%141.01M
17.76%183.98M
17.22%153.64M
28.10%146.82M
17.28%134.28M
8.85%156.23M
4.61%131.07M
-1.06%114.61M
8.20%114.50M
27.90%143.53M
74.47%125.30M
170.00%115.84M
Operating profit
64.87%-17.05M
70.02%-14.94M
23.97%-31.54M
74.67%-10.57M
18.30%-48.53M
-71.80%-49.84M
22.30%-41.48M
31.08%-41.74M
-14.25%-59.40M
-25.61%-29.01M
-33.50%-53.39M
4.05%-60.56M
-24.57%-51.99M
-45.90%-23.10M
-151.88%-40.00M
-523.19%-63.12M
-362.90%-41.73M
-793.34%-15.83M
31.90%-15.88M
73.98%-10.13M
Net Profit
60.80%-13.47M
66.85%-16.25M
23.16%-27.47M
191.14%34.54M
42.69%-34.36M
-0.16%-49.03M
61.55%-35.75M
39.28%-37.90M
-18.13%-59.95M
-184.36%-48.95M
-121.85%-92.99M
3.17%-62.41M
-19.65%-50.75M
6.69%-17.21M
-144.10%-41.91M
-483.22%-64.46M
-267.18%-42.41M
95.56%-18.45M
73.92%-17.17M
72.48%-11.05M
Balance Sheet
Current assets
15.52%669.73M
17.12%684.45M
11.10%659.83M
13.21%655.66M
2.23%579.73M
-1.95%584.39M
5.61%593.89M
-0.65%579.15M
-5.78%567.09M
-6.14%596.02M
-10.66%562.35M
-12.50%582.94M
-13.69%601.89M
-15.06%635.03M
-15.41%629.42M
-12.01%666.23M
-6.49%697.34M
-3.46%747.59M
-17.36%744.10M
67.67%757.17M
Total current liabilities
5.28%113.60M
30.45%153.45M
21.52%147.32M
1.08%112.22M
-0.77%107.90M
-7.49%117.63M
15.77%121.23M
13.18%111.02M
-2.92%108.73M
-2.90%127.16M
-17.45%104.72M
-16.81%98.09M
18.59%112.01M
18.67%130.96M
26.38%126.86M
4.23%117.91M
-21.65%94.45M
-6.58%110.36M
-31.05%100.38M
-7.41%113.13M
Total assets
12.44%1.02B
13.36%1.04B
9.55%1.03B
5.41%979.97M
-2.12%903.39M
-4.82%918.64M
-1.13%937.79M
-6.06%929.67M
-8.99%922.91M
-6.20%965.14M
-4.78%948.54M
-1.19%989.64M
1.07%1.01B
1.00%1.03B
0.57%996.21M
2.46%1.00B
5.16%1.00B
9.63%1.02B
-4.99%990.57M
67.74%977.58M
Total liabilities
2.51%201.44M
17.52%245.04M
12.68%242.24M
0.53%206.69M
-3.71%196.50M
-6.96%208.50M
5.74%214.99M
4.72%205.61M
-3.57%204.08M
0.39%224.10M
-7.75%203.32M
-9.97%196.34M
7.67%211.65M
10.92%223.24M
15.79%220.41M
13.00%218.07M
-2.48%196.57M
5.78%201.26M
-12.47%190.35M
0.76%192.99M
Total equity
15.20%814.32M
12.14%796.33M
8.62%785.12M
6.80%773.28M
-1.66%706.89M
-4.17%710.13M
-3.01%722.80M
-8.73%724.06M
-10.41%718.83M
-8.03%741.04M
-3.94%745.22M
1.25%793.30M
-0.53%802.38M
-1.45%805.74M
-3.05%775.79M
-0.14%783.52M
7.21%806.68M
10.62%817.57M
-3.01%800.22M
100.52%784.59M
Cash Flow Statement
Net operating income
-23.96%26.12M
704.28%40.78M
99.69%43.21M
136.23%17.71M
318.45%34.35M
-126.20%-6.75M
185.52%21.64M
165.04%7.50M
-281.21%-15.72M
87.70%25.76M
-164.58%-25.30M
32.05%-11.53M
80.17%-4.13M
136.40%13.72M
63.52%-9.56M
-643.69%-16.96M
-409.60%-20.80M
104.46%5.80M
52.87%-26.22M
110.57%3.12M
Net investment
30.74%-1.31M
96.50%-1.80M
-143.26%-8.80M
-107.86%-939.00K
-117.80%-1.89M
-493.89%-51.59M
-173.84%-3.62M
367.75%11.95M
-91.14%10.63M
139.49%13.10M
115.02%4.90M
83.79%-4.46M
146.57%119.96M
-20.11%-33.17M
-61.32%-32.63M
-88.96%-27.53M
-481.19%-257.56M
-24.04%-27.62M
-1444.05%-20.23M
-116.17%-14.57M
Net financing
-2094.55%-8.42M
-50.37%2.24M
295.51%617.00K
-23.48%3.52M
-74.24%422.00K
-19.53%4.52M
-96.43%156.00K
-35.13%4.60M
147.98%1.64M
12.24%5.61M
114.52%4.37M
11.57%7.10M
-241.25%-3.41M
-43.83%5.00M
-69.49%2.04M
-60.72%6.36M
-31.30%2.42M
15.53%8.90M
-98.63%6.68M
101.13%16.19M

FAQs

What is the total revenue of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its total revenue reached 642.82M, with a year-on-year change of 610.79M.

What are the current assets of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its current assets were 684.45M, with a year-on-year change of 17.12.

What are the total assets of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its total assets of 10X Genomics Inc were 1.04B, with a year-on-year change of 13.36.

What are the total liabilities of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its total liabilities of 10X Genomics Inc were 245.04M, with a year-on-year change of 17.52.

What is the total equity of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its total equity of 10X Genomics Inc was 796.33M, with a year-on-year change of 12.14.

What is the net operating income of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its net operating income of 10X Genomics Inc was -99.58M, with a year-on-year change of 48.26.

What is the net investment of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its net investment of 10X Genomics Inc was -13.44M, with a year-on-year change of 58.82.

What is the net financing of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its net financing of 10X Genomics Inc was 6.80M, with a year-on-year change of -37.67.

What is the Earnings Per Share (EPS) of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.35, with a year-on-year change of 76.98.

What is the net income of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its net income was -43.54M, with a year-on-year change of 76.16.

What is the net margin of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its net profit margin was -6.77, with a year-on-year change of 77.35.

What is the gross margin of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its gross margin was 69.13, with a year-on-year change of 1.80.

What is the Return on Equity (ROE) of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its Return on Equity (ROE) was -5.78, with a year-on-year change of 77.03.

What is the Return on Assets (ROA) of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its Return on Assets (ROA) was -4.44, with a year-on-year change of 77.08.

What is the operating profit of 10X Genomics Inc?

According to 10X Genomics Inc's FY2025 earnings report, its operating profit was -99.58M, with a year-on-year change of 48.26.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy